RU93058325A - Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в - Google Patents
Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита вInfo
- Publication number
- RU93058325A RU93058325A RU93058325/14A RU93058325A RU93058325A RU 93058325 A RU93058325 A RU 93058325A RU 93058325/14 A RU93058325/14 A RU 93058325/14A RU 93058325 A RU93058325 A RU 93058325A RU 93058325 A RU93058325 A RU 93058325A
- Authority
- RU
- Russia
- Prior art keywords
- hepatitis
- treatment
- application
- derivatives
- oxathyolane
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims 3
- WJJSZTJGFCFNKI-UHFFFAOYSA-N 1,3-oxathiolane Chemical class C1CSCO1 WJJSZTJGFCFNKI-UHFFFAOYSA-N 0.000 title claims 2
- 208000006454 hepatitis Diseases 0.000 title 2
- 231100000283 hepatitis Toxicity 0.000 title 2
- 208000036142 Viral infection Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (1)
- Предложено применять 1,3-оксатиолановые аналоги нуклеозида и их фармацевтически приемлемые производные для лечения инфекций вируса гепатита В. Предложены также фармацевтические препараты.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919109506A GB9109506D0 (en) | 1991-05-02 | 1991-05-02 | Therapeutic nucleosides |
| GB9109506.7 | 1991-05-02 | ||
| PCT/GB1992/000803 WO1992019246A1 (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU93058325A true RU93058325A (ru) | 1997-01-27 |
| RU2104700C1 RU2104700C1 (ru) | 1998-02-20 |
Family
ID=10694346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU93058325A RU2104700C1 (ru) | 1991-05-02 | 1992-05-01 | Способ лечения гепатита в |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0583274A1 (ru) |
| JP (1) | JPH06506929A (ru) |
| AU (1) | AU1662092A (ru) |
| CA (1) | CA2102120A1 (ru) |
| GB (1) | GB9109506D0 (ru) |
| IE (1) | IE921363A1 (ru) |
| IL (1) | IL101757A0 (ru) |
| MX (1) | MX9203214A (ru) |
| MY (1) | MY137298A (ru) |
| PT (1) | PT100435B (ru) |
| RU (1) | RU2104700C1 (ru) |
| UA (1) | UA37251C2 (ru) |
| WO (1) | WO1992019246A1 (ru) |
| ZA (1) | ZA923185B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
| US6175008B1 (en) | 1988-04-11 | 2001-01-16 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
| IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
| GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
| ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
| DE69912842T2 (de) | 1998-12-23 | 2004-05-13 | Shire Biochem Inc., Laval | Antivirale nukleosidanaloga |
| AR049297A1 (es) * | 2004-06-08 | 2006-07-12 | Vertex Pharma | Una composicion farmaceutica y dispersiones solidas de vx-950 (inhibidor de la proteasa de hcv ns3/4a) y proceso de obtencion |
| RU2331420C2 (ru) * | 2005-12-08 | 2008-08-20 | Роберт Шалвович Бибилашвили | Противовирусное средство (варианты) и способ лечения на его основе |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| CA2055433A1 (en) * | 1989-05-15 | 1990-11-16 | Jay H. Hoofnagle | Method of treatment of hepatitis |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
-
1991
- 1991-05-02 GB GB919109506A patent/GB9109506D0/en active Pending
-
1992
- 1992-04-30 PT PT100435A patent/PT100435B/pt not_active IP Right Cessation
- 1992-04-30 ZA ZA923185A patent/ZA923185B/xx unknown
- 1992-04-30 MY MYPI92000749A patent/MY137298A/en unknown
- 1992-05-01 CA CA002102120A patent/CA2102120A1/en not_active Abandoned
- 1992-05-01 WO PCT/GB1992/000803 patent/WO1992019246A1/en not_active Ceased
- 1992-05-01 JP JP4508657A patent/JPH06506929A/ja active Pending
- 1992-05-01 AU AU16620/92A patent/AU1662092A/en not_active Abandoned
- 1992-05-01 RU RU93058325A patent/RU2104700C1/ru active
- 1992-05-01 IL IL101757A patent/IL101757A0/xx unknown
- 1992-05-01 UA UA93004171A patent/UA37251C2/ru unknown
- 1992-05-01 EP EP92908933A patent/EP0583274A1/en not_active Withdrawn
- 1992-06-24 MX MX9203214A patent/MX9203214A/es unknown
- 1992-07-01 IE IE136392A patent/IE921363A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2105486A1 (en) | Therapeutic nucleosides | |
| MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
| RU94013464A (ru) | Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции | |
| WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
| RU93043875A (ru) | 1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-5-фторцитозин и способ лечения | |
| DK602988A (da) | Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser | |
| CA2271622A1 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
| ITMI931522A1 (it) | Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv) | |
| WO1998001144A2 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
| FI20001231A7 (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| NO875209D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 5-substituerte pyrimidin-nukleosider. | |
| EA199901031A1 (ru) | Производные бензимидазола | |
| DK92788A (da) | Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira | |
| MY127808A (en) | Use of dideoxy nucleoside analogues in the treatment of viral infections | |
| DE3679353D1 (de) | Antivirale verbindungen. | |
| RU93058325A (ru) | Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в | |
| DE69004451D1 (de) | Prophylaxe und Behandlung von Herpesvirus-Infektionen. | |
| LV10191A (lv) | Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai | |
| MY137298A (en) | Therapeutic nucleosides | |
| ATE122562T1 (de) | Derivate von penciclovir zur behandlung von hepatitis-b-infektionen. | |
| IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
| MY113560A (en) | Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b | |
| TH13799A (th) | สารต้าน-เอชบีวี พิริมิดีนนิวคลีโอไซด์ | |
| RU93046287A (ru) | Аминодиольные ингибиторы протеза | |
| TH10132A (th) | การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์ |